Full name
SANGUIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.90.E - Healthcare
47.73.Z - Retail sale of pharmaceutical products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
72.19.Z - Scientific research and development activities
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.90.A - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 4,8 | -0 | -1,3 | -5442,1 |
EBITDA | 4,8 | -0 | -1,3 | -5442,1 |
Short time liabilities | 69,5 | 61,6 | 76,1 | 23,6 |
Equity capital | 8,3 | 8,3 | 7 | -15,2 |
Operating profit (EBIT) | 4,8 | -0 | -1,3 | -5442,1 |
Assets | 77,9 | 69,9 | 83,1 | 19 |
Net profit (loss) | 4,4 | -0 | -1,3 | -5442,1 |
Cash | 2,7 | 1,1 | 3 | 178,6 |
Net income from sale | 203,4 | 811,8 | 798,6 | -1,6 |
Liabilities and provisions for liabilities | 69,5 | 61,6 | 76,1 | 23,6 |
Working assets | 77,9 | 69,9 | 83,1 | 19 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 53,1 | -0,3 | -18 | -17,7 |
Equity capital to total assets | 10,7 | 11,9 | 8,5 | -3,4 |
Gross profit margin | 2,4 | -0 | -0,2 | -0,2 |
EBITDA Margin | 2,4 | -0 | -0,2 | -0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 125 | 28 | 35 | 7 |
Current financial liquidity indicator | 1.119631290435791 | 1.1347559690475464 | 1.0924413204193115 | 0 |
Net dept to EBITDA | -0.5616124868392944 | 47.97938919067383 | 2.4120213985443115 | -45,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane